메뉴 건너뛰기




Volumn 16, Issue 3, 2009, Pages 436-437

Tapering versus cold turkey: Symptoms versus successful discontinuation of menopausal hormone therapy

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE;

EID: 67649884801     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181a057db     Document Type: Editorial
Times cited : (11)

References (12)
  • 2
    • 0032547326 scopus 로고    scopus 로고
    • Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group
    • Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-613.
    • (1998) JAMA , vol.280 , pp. 605-613
    • Hulley, S.1    Grady, D.2    Bush, T.3
  • 3
    • 0034099334 scopus 로고    scopus 로고
    • A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: Consensus opinion of The North American Menopause Society
    • The North American Menopause Society
    • The North American Menopause Society. A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society. Menopause 2000;7:76-86.
    • (2000) Menopause , vol.7 , pp. 76-86
  • 4
    • 0037125379 scopus 로고    scopus 로고
    • Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
    • Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
    • (2002) JAMA , vol.288 , pp. 321-333
    • Rossouw, J.E.1    Anderson, G.L.2    Prentice, R.L.3
  • 5
    • 1242334352 scopus 로고    scopus 로고
    • Treatment of menopause-associated vasomotor symptoms: Position statement of The North American Menopause Society
    • The North American Menopause Society
    • The North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2004;11:11-33.
    • (2004) Menopause , vol.11 , pp. 11-33
  • 6
    • 34247588730 scopus 로고    scopus 로고
    • Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society
    • The North American Menopause Society
    • The North American Menopause Society. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society. Menopause 2007;14:168-182.
    • (2007) Menopause , vol.14 , pp. 168-182
  • 7
    • 22144475839 scopus 로고    scopus 로고
    • Symptom experience after discontinuing use of estrogen plus progestin
    • Ockene JK, Barad DH, Cochrane BB, et al. Symptom experience after discontinuing use of estrogen plus progestin. JAMA 2005;294:183-193.
    • (2005) JAMA , vol.294 , pp. 183-193
    • Ockene, J.K.1    Barad, D.H.2    Cochrane, B.B.3
  • 8
    • 0344255781 scopus 로고    scopus 로고
    • Predictors of difficulty when discontinuing postmenopausal hormone therapy
    • Grady D, Ettinger B, Tosteson AN, Pressman A, Macer JL. Predictors of difficulty when discontinuing postmenopausal hormone therapy. Obstet Gynecol 2003;102:1233-1239.
    • (2003) Obstet Gynecol , vol.102 , pp. 1233-1239
    • Grady, D.1    Ettinger, B.2    Tosteson, A.N.3    Pressman, A.4    Macer, J.L.5
  • 9
    • 0037165669 scopus 로고    scopus 로고
    • A 60-year-old woman trying to discontinue hormone replacement therapy
    • Grady D. A 60-year-old woman trying to discontinue hormone replacement therapy. JAMA 2002;287:2130-2137.
    • (2002) JAMA , vol.287 , pp. 2130-2137
    • Grady, D.1
  • 10
    • 33745252191 scopus 로고    scopus 로고
    • Gradual discontinuation of hormone therapy does not prevent the reappearance of climacteric symptoms: A randomized prospective study
    • Haimov-Kochman R, Barak-Glantz E, Arbel R, et al. Gradual discontinuation of hormone therapy does not prevent the reappearance of climacteric symptoms: a randomized prospective study. Menopause 2006;13:370-376.
    • (2006) Menopause , vol.13 , pp. 370-376
    • Haimov-Kochman, R.1    Barak-Glantz, E.2    Arbel, R.3
  • 11
    • 33845461247 scopus 로고    scopus 로고
    • How best is to discontinue postmenopausal hormone therapy: Immediate or tapered?
    • Aslan E, Bagis T, Kilicdag EB, Tarim E, Erkanli S, Kuscu E. How best is to discontinue postmenopausal hormone therapy: immediate or tapered? Maturitas 2007;56:78-83.
    • (2007) Maturitas , vol.56 , pp. 78-83
    • Aslan, E.1    Bagis, T.2    Kilicdag, E.B.3    Tarim, E.4    Erkanli, S.5    Kuscu, E.6
  • 12
    • 67649878878 scopus 로고    scopus 로고
    • Discontinuing post-menopausal hormone therapy an observational study of tapering versus quitting cold turkey: Is there a difference in recurrence of menopausal symptoms
    • Haskell S, Bean-Mayberry B, Gordon K. Discontinuing post-menopausal hormone therapy an observational study of tapering versus quitting cold turkey: is there a difference in recurrence of menopausal symptoms. Menopause. 2009;16:494-499.
    • (2009) Menopause , vol.16 , pp. 494-499
    • Haskell, S.1    Bean-Mayberry, B.2    Gordon, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.